BIOM-13. DNA METHYLATION MARKS GLUCOCORTICOID PATHWAY RESPONSE IN DEXAMETHASONE-TREATED BRAIN TUMOR PATIENTS

Dexamethasone (DEX) is routinely prescribed in brain tumor patients to limit vasogenic edema but may also exacerbate immunosuppression and adversely affect survival. The wide spectrum of dosing and individual variation in glucocorticoid (GC) response makes it difficult to assess the impact of DEX ex...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Wiencke, John, Molinaro, Annette, Warrier, Gayathri, Rice, Terri, Clarke, Jennifer, Taylor, Jennie, Wrensch, Margaret, Tamaki, Stanley, Lee, JiYoon, Hansen, Helen, McCoy, Lucie, Bracci, Paige, Salas, Lucas, Koestler, Devin, Christensen, Brock, Kelsey, Karl
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2020
Sujets:
Biomarkers
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650309/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.013
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires